Using a Multiplex Suspension Bead Assay to Establish a Serocorrelate of Protection for Group B Streptococcus Disease

Speaker
  • Senior Technician at St George's, University of London

Abstract

Purpose:
Group B Streptococcus (GBS) is a Gram positive coccus which is part of the normal microbiota of the GI and GU tracts. However GBS is also a major cause of septicaemia and meningitis in newborns. Colonisation with GBS during pregnancy is a major risk factor for neonatal infection. Intrapartum antibiotic prophylaxis has greatly reduced incidence of early onset disease. However concerns over emerging antibiotic resistance and its impact on neonatal intestinal microbiota and a lack of protection afforded by intrapartum antibiotics outside of the first few days of life have led to GBS becoming a candidate for maternal vaccine development. Maternal IgG antibodies targeting capsular polysaccharides have been observed to provide protection against disease (Fabbrini et al 2016). Establishing a serocorrelate of protection could assist in the pathway to licensure of a GBS vaccine.

Methods:
A Bill and Melinda Gates Foundation funded consortium led by Kirsty Le Doare to establish a standardised multiplex immunoassay (MIA), based up luminex’s Xmap technology, and an opsonophagocytic killing assay (OPkA). This will be followed by a inter laboratory study between multiple partners to establish assay parameters and reproducibility.

Results:
Standardised reagents (CPS-PLL conjugates, standards) are being developed and characterised and preparations are being made for the inter laboratory study.

Conclusion:
Identifying a level of IgG which provides protection from GBS disease has been hampered by a lack of assay standardisation. A consortium has been established to develop standardised reagents and assays, including the multiplex immunoassay. Future studies to assess the relationship between antibody level, colonisation and disease are being planned.


Show Resources
You May Also Like
SEP 10, 2020 9:00 AM PDT
C.E. CREDITS
SEP 10, 2020 9:00 AM PDT
Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
APR 01, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
DEC 15, 2020 10:00 AM PST
C.E. CREDITS
DEC 15, 2020 10:00 AM PST
DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
APR 08, 2021 11:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
APR 08, 2021 11:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: April 8, 2021 Time: 11:00am (PDT), 3:00pm (EDT) Pneumonia is a deadly condition with clinical outcomes highly dependent on prompt and appropriate therapy. Diagnosis of pneumonia is cha...
DEC 03, 2020 4:30 PM PST
C.E. CREDITS
DEC 03, 2020 4:30 PM PST
This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...

Using a Multiplex Suspension Bead Assay to Establish a Serocorrelate of Protection for Group B Streptococcus Disease


No demographic data is available yet for this event.


Show Resources
Loading Comments...
Show Resources